Wen Y. Huang
No.6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Blood-brain barrier integrity disruption linked to brain lesions and relapse prediction in Southern Chinese anti-NMDAR encephalitis patients.
Journal: Frontiers in cellular neuroscience
Published: May 04, 2026
Correlation of cerebrospinal fluid and serum markers with EDSS-assessed baseline disability in multiple sclerosis patients.
Journal: Multiple sclerosis and related disorders
Published: March 03, 2026
Integrative Transcriptomics Identifies Ubiquitination-Related Genes BIRC2, COPS5, and TBK1 as Novel Biomarkers of T-Cell Dysregulation in Amyotrophic Lateral Sclerosis.
Journal: Journal of inflammation research
Published: December 03, 2025
Clinical and genetic analysis of a family with myopathy caused by an FHL1 gene variant.
Journal: BMJ neurology open
Published: June 30, 2025
The Value of Combined Detection of Systemic Inflammation Response Index and Prognostic Nutritional Index in Predicting Short-Term Prognosis of Myasthenia Gravis.
Journal: Journal of inflammation research
Published: June 24, 2025
FcRn inhibition with efgartigimod ameliorates muscle weakness and modulates dendritic cell subsets in an experimental autoimmune myasthenia gravis mouse model.
Journal: International immunopharmacology
Published: May 05, 2025
Oligoclonal Bands as Predictors of Disease Severity and Prognosis in Anti-NMDAR Encephalitis.
Journal: Journal of inflammation research
Published: April 22, 2025
Evaluation of blood-brain barrier integrity and clinical characteristics in autoimmune glial fibrillary acidic protein astrocytopathy.
Journal: Multiple sclerosis and related disorders
Published: March 29, 2025
Development of a novel diagnostic model for Alzheimer's disease based on glymphatic system and metabolism-related genes.
Journal: Frontiers in molecular biosciences
Published: March 01, 2025
The characteristics of new-onset myasthenia gravis after COVID-19 outbreak: a cross-sectional study.
The characteristics of new-onset myasthenia gravis after COVID-19 outbreak: a cross-sectional study.
Journal: Virology journal
Published: February 06, 2025
Efficacy of multi-cycle Efgartigimod in achieving minimal symptom expression in myasthenia gravis: A comparative multi-center study.
Journal: International immunopharmacology
Published: February 03, 2025
The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China.
Journal: Scientific reports
Published: December 22, 2024
Last Updated: 09/26/2026